Re-inventing tumor targeting

Best-in-class, TSL-based tumor targeting.
Explore the science behind Thermosome’s tumor targeting
Setting a new standard for the treatment of locally advanced soft tissue sarcoma.
Explore Thermosome’s pipeline
Experienced team of biotech entrepreneurs.
Get to know Thermosome’s team

Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.

Latest news

Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001

more news

Upcoming event

BIO International Convention

June 5-8, 2023
Boston, USA

more Events